Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2024 Jul 19;32(8):2800. doi: 10.1016/j.ymthe.2024.07.009

Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine

Saru Basnet, Mirte Van der Heijden, Dafne CA Quixabeira, Elise Jirovec, Susanna AM Grönberg-Vähä-Koskela, James HA Clubb, Anna Kanerva, Santeri Pakola, Lyna Haybout, Victor Arias, Otto Hemminki, Tatiana Kudling, Sadia Zafar, Victor Cervera-Carrascon, Joao M Santos, Akseli Hemminki ∗
PMCID: PMC11405147  PMID: 39029457

Main text

(Molecular Therapy, 32, https://doi.org/10.1016/j.ymthe.2024.06.029; September 2024)

In the originally published version of this article, Victor Cervera-Carrascon was mistakenly omitted from the author list. Dr. Cervera-Carrascon along with other authors designed the experiments for the study, and him being missing from the author list was the result of an error by the authors who assembled the author list. The authors apologize for any confusion this may have caused, and this error has been corrected in the paper online.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES